| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Beone Medicines Ltd. (ONC) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 65 sells. ONC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 4.58M | $1.25B | - | |
| Pres | 1.45M | $394.50M | - | |
| VP | 97.0K | $26.37M | - | |
| CEO | 3.3K | $888.2K | - | |
| Dir | 2.6K | $714.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Oyler John59 | Chief Executive Officer | Sell | 29,928 | $206.84 | $6,190,333.83 | -24.6% | +18.0% | -5.4% | |
| Nov 15, 2022 | Wang Xiaodong58 | Director, Chair, Scientific Advisory Brd | Sell | 1,987 | $210.14 | $417,541.42 | -100% | +18.0% | -5.4% | |
| Sep 21, 2022 | Oyler John59 | Chief Executive Officer | Sell | 50,000 | $152.13 | $7,606,556.24 | -52.6% | +40.2% | +26.2% | |
| Aug 8, 2022 | Wang Xiaodong58 | Director, Chair, Scientific Advisory Brd | Sell | 16,060 | $196.65 | $3,158,121.32 | -23.5% | -4.7% | -5.3% | |
| Jul 1, 2022 | Wang Julia Aijun54 | Chief Financial Officer | Sell | 295 | $158.50 | $46,757.50 | -100% | -18.4% | +6.8% | |
| Jun 27, 2022 | Wang Lai51 | Global Head Of R&D | Sell | 458 | $177.32 | $81,214.71 | -100% | -23.0% | +5.3% | |
| Jun 21, 2022 | Wang Lai51 | Global Head Of R&D | Sell | 1,168 | $145.35 | $169,767.41 | -61.8% | +1.4% | +21.6% | |
| Jun 21, 2022 | Wu Xiaobin54 | President, COO &Gm China | Sell | 1,588 | $142.63 | $226,494.81 | -61.1% | +1.4% | +21.6% | |
| Jun 17, 2022 | Wang Julia Aijun54 | Chief Financial Officer | Sell | 161 | $136.64 | $21,998.93 | -100% | +21.6% | +51.5% | |
| Jun 6, 2022 | Wang Lai51 | Global Head Of R&D | Sell | 660 | $142.00 | $93,717.56 | -100% | +18.1% | +63.4% |